Developments Hepion Pharma partners with University of Alberta’s Applied Pharmaceutical Innovation Hepion Pharmaceuticals (NASDAQ:HEPA) has partnered with Applied Pharmaceutical Innovation (API) to expand its research capabilities and further characterize its lead candidate, CRV431. API is an independent institute... July 31, 2019